Haran Burri, EHRA 2021: The Future of Pacing
Prof. Haran Burri (Lead Cardiac Physiologist, University of Oxford, Oxford, UK) gave us an update on the future of pacing from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021.
- What is the potential role of conduction system pacing as an alternative to biventricular pacing? (0.21)
- What have we learned from early clinical experience of leadless pacemakers and how is this technology likely to develop? (3.32)
Speaker disclosures: Prof. Haran Burri has received institutional fellowship and research support and speaker fees from Abbott, Biotronik, Boston Scientific, Medtronic and Microport.
Interview and filming supported by Touch Medical Media. Interview conducted by Heather Hall.
Filmed during a remote video call with Prof. Haran Burri as a highlight of EHRA 2021, May 2021
Share this Video
Related Videos In Devices
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Andrew Krahn: Heart Rhythm 2023 & HRX 2023 – The latest Innovations in arrhythmia care and technology
Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization dedicated to improving the care of patients with heart rhythm disorders […]
Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University of Pennsylvania, Philadelphia, PA, USA) to give a Neurologist’s perspective on the findings of the PROTECTED-TAVR […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!